Exelixis Inc (EXEL)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Michael M. Morrissey
Employees:
484
210 E. GRAND AVE, SOUTH SAN FRANCISCO, CA 94080
6508377000

Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its brands include COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization of cabozantinib. Exelixis was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in South San Francisco, CA.

Data derived from most recent annual or quarterly report
Market Cap 4.99 Billion Shares Outstanding315.049 Million Avg 30-day Volume 1.807 Million
P/E Ratio65.5144 Dividend Yield0.0 EPS-0.1
Price to Revenue5.9058 Debt to Equity0.0 EBITDA56.427 Million
Price to Book Value3.8867 Operating Margin4.1855 Enterprise Value5.914 Billion
Current Ratio6.723 EPS Growth-0.785 Quick Ratio6.39
1 Yr BETA 0.7538 52-week High/Low 25.77 / 15.74 Profit Margin5.1496
Operating Cash Flow Growth-54.3343 Altman Z-Score16.9819 Free Cash Flow to Firm -40.015 Million
View SEC Filings from EXEL instead.

View recent insider trading info

Funds Holding EXEL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EXEL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

150.2 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

115 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HALEY PATRICK J. EVP, COMMERCIAL

  • Officer
271,989 2021-11-24 9

FELDBAUM CARL B

  • Director
28,521 2021-11-19 3

MORRISSEY MICHAEL PRESIDENT AND CEO

  • Officer
  • Director
1,423,805 2021-11-15 6

LAMB PETER EVP, SCIENTIFIC STRATEGY & CSO

  • Officer
413,682 2021-11-15 15

HESSEKIEL JEFFREY EVP AND GENERAL COUNSEL

  • Officer
579,213 2021-11-15 9

SENNER CHRISTOPHER J. EVP AND CFO

  • Officer
360,538 2021-11-15 7

SCHWAB GISELA PRES, PROD DEV & MED AFF & CMO

  • Officer
703,958 2021-07-26 9

COHEN CHARLES

  • Director
261,375 2021-07-06 3

WYSZOMIERSKI JACK L

  • Director
256,486 2021-05-27 2

POSTE GEORGE

  • Director
173,614 2021-05-27 3

MARCHESI VINCENT T

  • Director
91,012 2021-05-27 3

PAPADOPOULOS STELIOS

  • Director
1,304,551 2021-05-27 2

WILLSEY LANCE

  • Director
33,549 2021-05-27 2

GARBER ALAN M

  • Director
33,549 2021-05-27 2

FREIRE MARIA C

  • Director
56,724 2021-05-27 2

SMITH JULIE

  • Director
32,725 2021-05-27 1

SCANGOS GEORGE A

  • Director
738,312 2020-05-18 0

BURKE DEBORAH SVP & CHIEF FINANCIAL OFFICER

  • Officer
19,990 2014-11-15 0

SIMONTON PAMELA A EVP, EXELIXIS

  • Officer
28,091 2014-02-15 0

KARBE FRANK EVP AND CFO

  • Officer
105,839 2014-02-15 0

MCCORMICK FRANK

  • Director
0 2013-12-06 0

GARLAND J. SCOTT EVP & CHIEF COMMERICAL OFFICER

  • Officer
0 2013-09-18 0

RIVERA LUPE M EVP, OPERATIONS

  • Officer
22,051 2011-08-15 0

HELLER FRANCES K EVP, BUSINESS DEVELOPMENT

  • Officer
17,254 2011-05-15 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2021-11-26 19:39:12 -0500 2021-11-24 S 17,236 $17.25 d 237,802 direct -0.7096 0.0 1 -0.7096 2

FELDBAUM CARL B - Director

2021-11-23 20:11:55 -0500 2021-11-19 S 20,000 $17.62 d 8,521 direct -2.4027 -5.7208 0.0 1 -6.1785 5

FELDBAUM CARL B - Director

2021-11-23 20:11:55 -0500 2021-11-19 M 20,000 $3.13 a 28,521 direct -2.4027 -5.7208 0.0 1 -6.1785 5

FELDBAUM CARL B - Director

2021-11-23 20:11:55 -0500 2021-11-19 M 20,000 d 20,000 direct

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2021-11-17 20:40:45 -0500 2021-11-15 F 983 $18.10 d 299,222 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2021-11-17 20:39:03 -0500 2021-11-15 F 2,566 $18.10 d 404,735 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2021-11-17 20:37:42 -0500 2021-11-15 F 1,311 $18.10 d 624,957 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 F 53,022 $18.10 d 349,077 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 S 47,500 $18.09 d 411,240 direct yes 3.0875 -2.4585 3.0875 2 -2.4585 6

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2021-11-17 20:33:10 -0500 2021-11-15 F 6,118 $18.10 d 544,420 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2021-11-17 20:40:45 -0500 2021-11-15 F 4,323 $18.10 d 300,205 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2021-11-17 20:39:03 -0500 2021-11-15 F 8,227 $18.10 d 407,301 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2021-11-17 20:37:42 -0500 2021-11-15 F 6,557 $18.10 d 626,268 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 F 2,323 $18.10 d 402,099 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 M 47,500 $6.21 a 458,740 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2021-11-17 20:33:10 -0500 2021-11-15 F 10,530 $18.10 d 550,538 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HALEY PATRICK J. - Officer EVP, COMMERCIAL

2021-11-17 20:40:45 -0500 2021-11-15 F 44,184 $18.10 d 255,038 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

SENNER CHRISTOPHER J. - Officer EVP AND CFO

2021-11-17 20:39:03 -0500 2021-11-15 F 46,920 $18.10 d 357,815 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2021-11-17 20:37:42 -0500 2021-11-15 F 46,743 $18.10 d 578,214 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 M 47,500 d 47,500 direct

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-11-17 20:02:39 -0500 2021-11-15 F 6,818 $18.10 d 404,422 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2021-11-17 20:33:10 -0500 2021-11-15 F 177,132 $18.10 d 367,288 direct 3.0875 -2.4585 3.0875 2 -2.4585 6

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2021-11-03 20:12:56 -0400 2021-11-01 S 5,117 $22.03 d 632,825 direct yes 2.2715 -5.7581 2.2715 2 -5.7581 6

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2021-10-22 20:19:59 -0400 2021-10-22 F 24,747 $21.33 d 561,068 direct 0.1387 0.3236 0.601 4 -1.5257 3

MORRISSEY MICHAEL - Director - Officer PRESIDENT AND CEO

2021-10-22 20:19:59 -0400 2021-10-22 A 94,002 a 585,815 direct 0.1387 0.3236 0.601 4 -1.5257 3

HESSEKIEL JEFFREY - Officer EVP AND GENERAL COUNSEL

2021-10-15 20:14:09 -0400 2021-10-15 S 12,883 $22.02 d 637,942 direct yes 0.8916 1.5016 -21.2107 2.6748 12 -21.2107 31

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-10-15 20:15:39 -0400 2021-10-15 S 47,500 $21.92 d 411,240 direct yes 0.8916 1.5016 -21.2107 2.6748 12 -21.2107 31

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-10-15 20:15:39 -0400 2021-10-15 M 47,500 $6.21 a 458,740 direct 0.8916 1.5016 -21.2107 2.6748 12 -21.2107 31

LAMB PETER - Officer EVP, SCIENTIFIC STRATEGY & CSO

2021-10-15 20:15:39 -0400 2021-10-15 M 47,500 d 95,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EXELIXIS INC EXEL 2021-12-03 22:15:03 UTC -0.1855 0.2555 9300000
EXELIXIS INC EXEL 2021-12-03 21:45:03 UTC -0.1855 0.2555 9300000
EXELIXIS INC EXEL 2021-12-03 21:15:04 UTC -0.1855 0.2555 9300000
EXELIXIS INC EXEL 2021-12-03 20:45:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 20:15:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 19:45:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 19:15:04 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 18:45:04 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 18:15:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 17:45:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 17:15:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 16:45:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 16:15:04 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 15:45:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 15:15:03 UTC -0.1839 0.2539 9300000
EXELIXIS INC EXEL 2021-12-03 14:45:03 UTC -0.182 0.252 9300000
EXELIXIS INC EXEL 2021-12-03 14:15:05 UTC -0.182 0.252 9300000
EXELIXIS INC EXEL 2021-12-03 13:45:03 UTC -0.182 0.252 9300000
EXELIXIS INC EXEL 2021-12-03 13:15:03 UTC -0.182 0.252 9300000
EXELIXIS INC EXEL 2021-12-03 12:45:03 UTC -0.182 0.252 9300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Defensive Long Fund EXEL -162.0 shares, $-2789.64 2020-03-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund EXEL -90.0 shares, $-2200.5 2020-09-30 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND EXEL -5932.0 shares, $-99954.2 2021-07-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF EXEL -15920.0 shares, $-336548.8 2021-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund EXEL -2452.0 shares, $-51835.28 2021-09-30 N-PORT

Elevate your investments